The Growing Market for Chronic Lower Back Pain (CLBP)

Chronic lower back pain (CLBP) is the second leading cause of disability worldwide. The prevalence of CLBP in adults has grown significantly over the last ten years.

Topics: Pharmaceuticals Healthcare Industry Insights

The State of the Medical Marijuana Market in 2020

Cannabis culture is not new and is not restricted to recreational purposes. The use of cannabis, a.k.a. marijuana, for medicinal purposes such as joint pain, muscle spasms, gout, spinal cord injury, and insomnia, dates back to as early as 5000 BC.

Topics: Pharmaceuticals Industry Insights

Infographic: Non-Small Cell Lung Cancer (NSCLC) Market Insights

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and accounted for around 85% of all lung cancers in the United States.

Topics: Pharmaceuticals Industry Insights

$71 Billion U.S. Weight Loss Industry Pivots to Survive Pandemic

The total U.S. weight loss market hit a new peak in 2019, growing to $78 billion. However, that growth came to a halt when the Coronavirus hit in March, shutting the doors of weight loss centers, doctors’ offices, clinics, and other businesses for 8-10 weeks. As a result, the value of the market is forecast to decline by 9% this year.

Topics: Food & Beverage Pharmaceuticals Healthcare Industry Insights

How Artificial Intelligence Is Intensifying the Fight Against COVID-19

It is a major cause for concern that there is no proper vaccination and official treatment available that can help mitigate the coronavirus pandemic so far. Thus, it is imperative for researchers and scientists to explore different approaches and devise ways to counter this global health crisis.

Topics: Software & Enterprise Computing Pharmaceuticals Healthcare Industry Insights

Top Therapeutic Drugs Targeting the Novel Coronavirus COVID-19

The novel coronavirus, SARS-CoV-2, also known as COVID-19, has now become a pandemic, leaving all healthcare institutions and government officials baffled, and researchers and scientists on high alert.

Topics: Pharmaceuticals Industry Insights

COVID-19: How It's Different from Previous Pandemics and How It's Impacting World Economies

In light of the ongoing COVID-19 (coronavirus) pandemic, it is imperative to understand the origin of this virus. Previously, such pandemics were often a result of the spread of viruses such as H1N1, H5N1, and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), among others.

Topics: Pharmaceuticals Healthcare Industry Insights

The Digital Biomarkers Market: Key Drivers and Challenges

An increased usage of digital tools, including smartphones and wearables, among others, has led to an expansion in collected health information.

The health data gathered by these devices also includes biomarker-related data — objective signals that are medically relevant and can be highly insightful for formulating treatments for patients, especially those who are suffering from chronic diseases.

Topics: Pharmaceuticals Industry Insights

Beyond the Coronavirus: China Pharma Market Set to Grow

Every news service globally is focused on COVID-19 (the “coronavirus”) and how it will affect the global population, but what of the Chinese health system itself? How does this sector operate during “normal” times? What will drive and restrain Chinese health markets?

These are some of the questions we have been looking at over the past 6 months.

Topics: Pharmaceuticals Industry Insights

Global Organ-on-Chips Market Worth $41.6 Million

Organ-on-chips (OOCs) are small plastic devices with biocompatible microfluid chambers containing multiple live human cells in a 3D culture that stimulate key physiological functions of body organs. The organ-on-chip market has grown 70.5% since 2015, reaching nearly $41.6 million in 2019, according to a report by The Business Research Company.

Topics: Biotechnology Pharmaceuticals Industry Insights